Atlas Trials

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

Clinical trial NCT02138422 · COMPLETED

Trial details

NCT number
NCT02138422
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Symptomatic Colorectal CancerAdvanced Colorectal CancerColorectal Cancer With Cachexia
Start date
2014-07-31
Primary completion
2015-11-30
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.